Literature DB >> 7048940

The antimicrobial removal device. A microbiological and clinical evaluation.

A J Wright, R L Thompson, C A McLimans, W R Wilson, J A Washington.   

Abstract

A parallel study of blood cultured conventionally and following processing in an Antimicrobial Removal Device (ARD) was conducted with patients suspected of being clinically bacteremic. Cultures yielded 205 isolates from 87 clinically bacteremic patients, of whom 28 were receiving antibiotics at the time their cultures were performed. Overall, ARD processing neither increased the isolation rate nor decreased the time interval required for detection of organisms compared with conventional processing. ARD processing was the only means of isolation of organisms from only seven of the 87 patients and three of the 28 receiving antibiotics, whereas conventional processing accounted for the only means of isolation of organisms from 17 of the 87 patients and nine of the 28 receiving antibiotics. ARD processing demonstrated no advantages over conventional processing of blood cultures.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7048940     DOI: 10.1093/ajcp/78.2.173

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  20 in total

1.  Detection of borreliacidal antibodies in Lyme borreliosis patient sera containing antimicrobial agents.

Authors:  D A Jobe; N Rawal; R F Schell; S M Callister
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

2.  Cost effectiveness of the antibiotic removal device for processing blood cultures.

Authors:  M I de Silva; S M Qadri; E Hood
Journal:  J Natl Med Assoc       Date:  1986-09       Impact factor: 1.798

3.  Effectiveness of resins in neutralizing antibiotic activities in bactec plus Aerobic/F culture medium.

Authors:  J Spaargaren; C P van Boven; G P Voorn
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

4.  Detection of bacteria in the presence of antibiotics by using specific monoclonal antibodies to neutralize the antibiotics.

Authors:  J G Sierra-Madero; M J Caulfield; G S Hall; J A Washington
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

5.  Clinical comparison of the recoveries of bloodstream pathogens in Septi-Chek brain heart infusion broth with saponin, Septi-Chek tryptic soy broth, and the isolator lysis-centrifugation system.

Authors:  P R Murray; A W Spizzo; A C Niles
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

6.  Controlled evaluation of BACTEC Plus 26 and Roche Septi-Chek aerobic blood culture bottles.

Authors:  M P Weinstein; S Mirrett; M L Wilson; L J Harrell; C W Stratton; L B Reller
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

7.  Routine evaluation of BACTEC NR-16A and NR-17A media.

Authors:  R J Courcol; A V Durocher; M Roussel-Delvallez; A Fruchart; G R Martin
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

Review 8.  Current controversies in the detection of septicemia.

Authors:  G Pierce; P R Murray
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

9.  Evaluation of the BACTEC antimicrobial removal system for detection of bacteremia.

Authors:  N M McGuire; C A Kauffman; C S Hertz; J M Kovach
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

10.  In vitro evaluation of the BACTEC resin-containing blood culture bottle.

Authors:  S M Smith; R H Eng
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.